CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 4 Grant or award Director acquired 852 shares (grant or award)
- 4 Grant or award Director acquired 7,754 shares (grant or award)
- 4 Grant or award Director acquired 4,109 shares (grant or award)
- 4 Planned sale EVP, General Counsel sold 440 shares at $8.35 ($3,674)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 842 shares (grant or award)
- 4 Grant or award Director acquired 4,059 shares (grant or award)
- 4 Grant or award Director acquired 7,659 shares (grant or award)
- SD Other Specialized Disclosure
- 4 Planned sale EVP, General Counsel sold 13,370 shares at $6.21 ($83,028)
- 4 Shares withheld for taxes SVP, Controller & CAO gave up 3,982 shares (to pay taxes)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Executive Officer gave up 14,683 shares (to pay taxes)
- SC 13G Stake Amended Statement of Ownership
- 4 Grant or award EVP, CFO acquired 298,838 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
Page 9 of 121 · 2,419 filings